ES8200655A1 - Procedimiento para la preparacion de sulfonamidas - Google Patents

Procedimiento para la preparacion de sulfonamidas

Info

Publication number
ES8200655A1
ES8200655A1 ES498308A ES498308A ES8200655A1 ES 8200655 A1 ES8200655 A1 ES 8200655A1 ES 498308 A ES498308 A ES 498308A ES 498308 A ES498308 A ES 498308A ES 8200655 A1 ES8200655 A1 ES 8200655A1
Authority
ES
Spain
Prior art keywords
formula
preparation
acid
sulphonamides
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES498308A
Other languages
English (en)
Other versions
ES498308A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES498308A0 publication Critical patent/ES498308A0/es
Publication of ES8200655A1 publication Critical patent/ES8200655A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Devices That Are Associated With Refrigeration Equipment (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE SULFONAMIDAS DE FORMULA (I), EN QUE R ES HIDROGENO O UN GRUPO ALCOHILO, ARILO, ARALCOHILO O ARALQUENILO Y W UN ENLACE O UNA CADENA SATURADA O CONTENIENDO UN DOBLE ENLACE. SE OBTIENE POR LA REACCION DE UNA AMINA DE FORMULA (II_), EN QUE Y ES UN GRUPO CARBOXILO, CON UN ACIDO SULFONICO DE FORMULA (III) EN PRESENCIA DE UN AGENTE FIJADOR DE ACIDOS. O BIEN POR TRANSACILACION DEL ACIDO SULFONICO DE FORMULA (III) CON UNA ACILAMINA, EN UN DISOLVENTE POLAR A LA TEMPERATURA DE EBULLICION DEL DISOLVENTE. OPCIONALMENTE, EL COMPUESTO OBTENIDO SE ALCOHILA EN NITROGENO EN PRESENCIA DE UN AGENTE FIJADOR DE ACIDOS. SE USAN COMO AGENTES HIPOLIPIDEMICOS E INHIBIDORES DE LA AGLOMERACION DE TROMBOCITOS.
ES498308A 1980-01-07 1981-01-03 Procedimiento para la preparacion de sulfonamidas Expired ES8200655A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803000377 DE3000377A1 (de) 1980-01-07 1980-01-07 Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES498308A0 ES498308A0 (es) 1981-12-01
ES8200655A1 true ES8200655A1 (es) 1981-12-01

Family

ID=6091629

Family Applications (1)

Application Number Title Priority Date Filing Date
ES498308A Expired ES8200655A1 (es) 1980-01-07 1981-01-03 Procedimiento para la preparacion de sulfonamidas

Country Status (22)

Country Link
US (1) US4443477A (es)
EP (1) EP0031954B1 (es)
JP (1) JPS56100757A (es)
AT (1) ATE6641T1 (es)
AU (1) AU538993B2 (es)
CA (1) CA1241341A (es)
CS (1) CS238611B2 (es)
DD (1) DD157190A5 (es)
DE (2) DE3000377A1 (es)
ES (1) ES8200655A1 (es)
FI (1) FI73667C (es)
GR (1) GR72486B (es)
HK (1) HK68887A (es)
IE (1) IE50657B1 (es)
IL (1) IL61834A (es)
PH (1) PH18739A (es)
PL (1) PL127050B1 (es)
PT (1) PT72305B (es)
SG (1) SG2387G (es)
SU (1) SU1088664A3 (es)
YU (1) YU42995B (es)
ZA (1) ZA8132B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401663A (en) * 1981-06-30 1983-08-30 The Procter & Gamble Company Novel sulfonamide derivatives
AU567140B2 (en) * 1984-01-06 1987-11-12 Shionogi & Co., Ltd. Sulphonamido-benzamide derivatives
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
US4689182A (en) * 1985-12-20 1987-08-25 Warner-Lambert Company Benzoic acid and benzoic acid ester derivatives having anti-inflammatory and analgesic activity
FR2598412B1 (fr) * 1986-03-12 1988-10-21 Sanofi Sa Nouveaux derives de diarylcetones et leurs procedes de preparation et les compositions pharmaceutiques les contenant
IL83230A (en) * 1986-08-06 1992-06-21 Tanabe Seiyaku Co Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them
DE3629929A1 (de) * 1986-09-03 1988-03-10 Thomae Gmbh Dr K Neue sulfonamido-aethylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
ES2036213T3 (es) * 1986-10-28 1993-05-16 Smith Kline & French Laboratories Limited Procedimiento para preparar derivados tetrahidroisoquinolin-1-ilicos de acidos carboxilicos.
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
KR880012221A (ko) * 1987-04-13 1988-11-26 사노 가즈오 에스테르 또는 아미드를 활성성분으로 함유하는 약제 조성물
CA1294974C (en) * 1987-05-08 1992-01-28 Sanji Hagishita Bicyclic sulfonamide derivatives and process therefor
US4752616A (en) * 1987-06-29 1988-06-21 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, compositions containing same and method of use
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
US4752613A (en) * 1987-08-03 1988-06-21 E. R. Squibb & Sons, Inc. Sulphonamidothienylcarboxylic acid compounds
US4783473A (en) * 1987-09-02 1988-11-08 E. R. Squibb & Sons, Inc. Geminally substituted cyclic ether carboxylic acids, derivatives thereof, compositions containing same and method of use
US4931460A (en) * 1987-09-17 1990-06-05 E. R. Squibb & Sons, Inc. Post-ischemic myocardial dysfunction using thromboxane A2 antagonists
JPH01175962A (ja) * 1987-12-28 1989-07-12 Tanabe Seiyaku Co Ltd フェニル酢酸誘導体
EP0325245B1 (en) * 1988-01-19 1993-10-20 Tanabe Seiyaku Co., Ltd. Phenoxyacetic acid derivatives, preparation thereof, pharmaceutical compositions comprising them and use
US5066480A (en) * 1988-04-11 1991-11-19 E. R. Squibb & Sons, Inc. Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist
DE3819052A1 (de) * 1988-06-04 1989-12-07 Basf Ag Neue sulfonamid-derivate, ihre herstellung und verwendung
DE3829455A1 (de) * 1988-08-31 1990-03-15 Boehringer Mannheim Gmbh Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US5280043A (en) * 1988-10-10 1994-01-18 Smith Kline & French Laboratories Ltd. Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
GB8823731D0 (en) * 1988-10-10 1988-11-16 Smith Kline French Lab Biologically active compounds
US5006542A (en) * 1988-10-31 1991-04-09 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use
US5070099A (en) * 1988-10-31 1991-12-03 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same method of use
US4959383A (en) * 1988-10-31 1990-09-25 E. R. Squibb & Sons, Inc. Phenylsulfone alkenoic acids, derivatives thereof, compositions containing same and method of use
US5106991A (en) * 1989-06-02 1992-04-21 E. R. Squibb & Sons, Inc. Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof
US4975452A (en) * 1989-06-02 1990-12-04 E. R. Squibb & Sons, Inc. Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof
US5153214A (en) * 1989-06-28 1992-10-06 Ciba-Geigy Corporation Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
US5025025A (en) * 1989-06-28 1991-06-18 Ciba-Geigy Corporation (Arylsulfonamido- and pyridyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity
DE4010536A1 (de) * 1990-04-02 1991-10-10 Boehringer Mannheim Gmbh Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure
FR2665440B1 (fr) * 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
US5189211A (en) * 1990-08-01 1993-02-23 Taisho Pharmaceutical Co., Ltd. Sulfonamide derivatives
US5409959A (en) * 1991-01-29 1995-04-25 Genelabs Incorporated Antithrombotic treatment with calix(n)arene compounds
DE4109735A1 (de) * 1991-03-25 1992-10-01 Boehringer Mannheim Gmbh Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US5280034A (en) * 1991-08-23 1994-01-18 E. R. Squibb & Sons, Inc. Bis-heterocyclic prostaglandin analogs
US5827868A (en) * 1991-10-07 1998-10-27 E. R. Squibb & Sons, Inc. Prostaglandin analogs
TW219358B (es) * 1991-12-20 1994-01-21 Hokuriku Pharmaceutical
GB9220137D0 (en) * 1992-09-23 1992-11-04 Pfizer Ltd Therapeutic agents
JPH0753505A (ja) * 1992-10-01 1995-02-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びその用途
CA2244785C (en) * 1996-02-22 2003-12-02 Tularik, Inc. Pentafluorobenzenesulfonamides and analogs
ES2201313T3 (es) * 1996-07-19 2004-03-16 Tularik, Inc. Pentafluorobencenosulfonamidas y analogos.
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
FR2760235B1 (fr) * 1997-02-28 1999-04-09 Adir Nouveaux derives de benzenesulfonylamine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UA67754C2 (uk) 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
US6693137B1 (en) * 1998-07-31 2004-02-17 Eli Lilly And Company Sulphonamide derivatives
PL356662A1 (en) 1999-12-22 2004-06-28 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
US20050250854A1 (en) * 2000-11-03 2005-11-10 Amgen Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
US6822001B2 (en) 2000-11-03 2004-11-23 Tularik Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
CA2584413A1 (en) * 2004-10-29 2006-05-04 Astrazeneca Ab Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
TW200829578A (en) 2006-11-23 2008-07-16 Astrazeneca Ab Chemical compounds 537
JO2754B1 (en) 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
BRPI0810609A2 (pt) * 2007-04-27 2014-10-21 Tibotec Pharm Ltd Métodos para a preparação de derivados de n-isobutil-n-(2-hidróxi-a-amino-4-fenilbutil)-p-nitrobe nzenossulfonilamida
TWI445705B (zh) 2008-05-20 2014-07-21 Astrazeneca Ab 經苯基及苯并二基取代之吲唑衍生物
MX2011000051A (es) * 2008-07-07 2011-07-28 Fasgen Inc Nuevos compuestos, composiciones farmaceuticas que contienen los mismos, metodos para usar los mismos, y metodos para preparar los mismos.
ES2863538T3 (es) * 2012-09-20 2021-10-11 Univ Temple Derivados de alquil diarilo sustituidos, métodos de preparación y usos
US9693998B2 (en) 2014-05-16 2017-07-04 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
US12161632B2 (en) 2014-05-16 2024-12-10 Cumberland Pharmaceuticals Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
AU2016285566A1 (en) 2015-06-30 2017-12-14 Cumberland Pharmaceuticals, Inc. Thromboxane receptor antagonists in AERD/asthma
US10383831B2 (en) 2015-08-03 2019-08-20 Temple University—Of the Commonwealth System of Higher Education 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use
EP3454850B1 (en) 2016-05-11 2023-06-21 Cumberland Pharmaceuticals Inc. Compositions and methods of treating muscular dystrophy with thromboxane-a2 receptor antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE542184A (es) * 1954-10-21
US3027405A (en) * 1959-07-29 1962-03-27 Geigy Chem Corp Nu-(alkylarylsulfonyl)-amino acids and salts thereof
US3991106A (en) * 1974-09-13 1976-11-09 Merck & Co., Inc. 16-Ethers of 8-aza-9-dioxothia-11,12-seco-prostaglandins
DK148576A (da) * 1975-04-18 1976-10-19 Boehringer Mannheim Gmbh Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
US4112236A (en) * 1977-04-04 1978-09-05 Merck & Co., Inc. Interphenylene 8-aza-9-dioxothia-11,12-secoprostaglandins
GB1572201A (en) * 1977-04-05 1980-07-23 Bristol Myers Co Cephalosporins
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3000519A1 (de) * 1979-02-01 1980-08-14 Byk Gulden Lomberg Chem Fab Sulfonamido-alkansaeuren, ihre verwendung und herstellung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
ZA8132B (en) 1982-02-24
JPS56100757A (en) 1981-08-12
PT72305A (de) 1981-02-01
PH18739A (en) 1985-09-16
US4443477A (en) 1984-04-17
HK68887A (en) 1987-10-02
DE3000377A1 (de) 1981-07-09
IL61834A0 (en) 1981-01-30
IE50657B1 (en) 1986-06-11
DE3067068D1 (en) 1984-04-19
YU42995B (en) 1989-02-28
FI73667C (fi) 1987-11-09
PT72305B (de) 1981-12-17
DD157190A5 (de) 1982-10-20
FI73667B (fi) 1987-07-31
YU881A (en) 1983-10-31
SU1088664A3 (ru) 1984-04-23
JPS6352625B2 (es) 1988-10-19
ATE6641T1 (de) 1984-03-15
AU538993B2 (en) 1984-09-06
ES498308A0 (es) 1981-12-01
AU6597481A (en) 1981-07-16
IL61834A (en) 1984-06-29
EP0031954A3 (en) 1981-11-11
FI804085L (fi) 1981-07-08
CS238611B2 (en) 1985-12-16
EP0031954A2 (de) 1981-07-15
SG2387G (en) 1987-11-13
PL127050B1 (en) 1983-09-30
IE810006L (en) 1981-07-07
CA1241341A (en) 1988-08-30
GR72486B (es) 1983-11-14
PL229072A1 (es) 1982-04-26
EP0031954B1 (de) 1984-03-14

Similar Documents

Publication Publication Date Title
ES8306122A1 (es) Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES8206491A1 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina.
ES8600210A1 (es) Un procedimiento para la preparacion de nuevos derivados de arilamida
ES8306750A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
DK131481A (da) Fremgangsmaade til fremstilling af oxiransmoersyrederivater
ES8608502A1 (es) Procedimiento para la obtencion de benzofuranonas
ES8303424A1 (es) Procedimiento para la obtencion de esteres del acido 7b-(2-(2-animo-4-tiazolil)-2-(sin)-metoxiimino-acetamido)-3-cefem-4-caboxilico.
ES8205407A1 (es) Un procedimiento de preparacion de compuestos intermedios para la produccion de picropodofilina.
ES8603810A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dietilaminoalcoxi sustituido y sus sales deadicion acidas y amonicas cuaternarias
ES8107192A1 (es) Un procedimiento para la preparacion de un compuesto sele- ccionado entre el grupo formado por una imidazolilurea
DK551885D0 (da) Middel og fremgangsmaade til efterbehandling af vasket vasketoej
ES8301216A1 (es) Un procedimiento para la preparacion de derivados de enantolactama.
ES8202339A1 (es) Un procedimiento para preparar una pirazolopiridina
ES8603834A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piridinometoxi sustituido y de sus sales deadicion acidas y cuaternarias
ES8601211A1 (es) Procedimiento para la preparacion de nuevos derivados de sinergistinas
ES8607922A1 (es) Procedimiento para preparar 9-oxo-15 a-hidroxi-16-fenoxi y 16-fenoxi sustituido-17,18,19,20-tetranorprosta-4,5,13 (e)- trienoatos
ES2055089T3 (es) Procedimiento para preparar 4-metilpirazoles.
ES8303333A1 (es) Procedimiento para preparar derivados de indol o de indolina.
ES8607971A1 (es) Procedimiento para la obtencion de compuestos de 2-heterociclil-tio-alquilo inferior-penem
ES8403482A1 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas.
ES8402157A1 (es) Un procedimiento para la preparacion de ciertos carbonatos de 6-(2-amino-2-fenil-acetamido-penicilanoiloximetil)-1,1-dioxopenicilanoiloximetilo como agentes antibacterianos.
ES8609219A1 (es) Un procedimiento para producir un derivado de difenilmetilimina
ES461253A1 (es) Un procedimiento para la produccion de dihidro-piran-3-ona.
MX3292E (es) Procedimiento mejorado para la preparacion de un acido indanil propionico
ES8205217A1 (es) Un procedimiento para la produccion de derivados de 1,2,4-triazina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010201